Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak

Chemotherapy schedule modifications are done in clinical practice due to treatment complications or the patients preference. Multiple clinical studies have established the negative prognostic impact of dose delay on survival rates. This study aims to investigate the prevalence and reason for chemoth...

Full description

Saved in:
Bibliographic Details
Main Author: Gunasekaran, Gobi Hariyanayagam
Format: Thesis
Language:English
Published: 2021
Subjects:
Online Access:http://eprints.usm.my/52695/1/GOBI%20HARIYANAYAGAM%20AL%20GUNASEKARAN%20-%20TESIS24.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.52695
record_format uketd_dc
spelling my-usm-ep.526952022-05-31T17:57:53Z Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak 2021-10 Gunasekaran, Gobi Hariyanayagam RS1-441 Pharmacy and materia medica Chemotherapy schedule modifications are done in clinical practice due to treatment complications or the patients preference. Multiple clinical studies have established the negative prognostic impact of dose delay on survival rates. This study aims to investigate the prevalence and reason for chemotherapy schedule modification with the impact of schedule modification on the Overall Survival (OS) of the breast cancer patient. This retrospective cohort study was done among breast cancer patients receiving chemotherapy from 2013 to 2017 and was followed until 31 Dec 2018. Medical records of patients with cancer were reviewed. Inclusion criteria involved the female patients over eighteen years old, primary carcinoma of the breast, received Anthracycline or Taxane based chemotherapy regimen and completed more than two cycles of chemotherapy. Patients were categorised into three categories of no schedule modification, with schedule modification, and incomplete schedule. The Kaplan-Meier were used to test for survival differences in the univariate setting, and the Cox regression model was used in the multivariate setting. This study aims to measure the prevalence, OS rates, and Hazard Risk (HR) of these three treatment categories. Among 171 patients receiving chemotherapy, 28 (16.4%) had no schedule modification, 118 (69.0%) had schedule modification, and the remaining 25 (14.6%) had an incomplete schedule with OS of 75.0%, 59.3%, and 52.0%, respectively 2021-10 Thesis http://eprints.usm.my/52695/ http://eprints.usm.my/52695/1/GOBI%20HARIYANAYAGAM%20AL%20GUNASEKARAN%20-%20TESIS24.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Farmasi
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic RS1-441 Pharmacy and materia medica
spellingShingle RS1-441 Pharmacy and materia medica
Gunasekaran, Gobi Hariyanayagam
Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
description Chemotherapy schedule modifications are done in clinical practice due to treatment complications or the patients preference. Multiple clinical studies have established the negative prognostic impact of dose delay on survival rates. This study aims to investigate the prevalence and reason for chemotherapy schedule modification with the impact of schedule modification on the Overall Survival (OS) of the breast cancer patient. This retrospective cohort study was done among breast cancer patients receiving chemotherapy from 2013 to 2017 and was followed until 31 Dec 2018. Medical records of patients with cancer were reviewed. Inclusion criteria involved the female patients over eighteen years old, primary carcinoma of the breast, received Anthracycline or Taxane based chemotherapy regimen and completed more than two cycles of chemotherapy. Patients were categorised into three categories of no schedule modification, with schedule modification, and incomplete schedule. The Kaplan-Meier were used to test for survival differences in the univariate setting, and the Cox regression model was used in the multivariate setting. This study aims to measure the prevalence, OS rates, and Hazard Risk (HR) of these three treatment categories. Among 171 patients receiving chemotherapy, 28 (16.4%) had no schedule modification, 118 (69.0%) had schedule modification, and the remaining 25 (14.6%) had an incomplete schedule with OS of 75.0%, 59.3%, and 52.0%, respectively
format Thesis
qualification_level Master's degree
author Gunasekaran, Gobi Hariyanayagam
author_facet Gunasekaran, Gobi Hariyanayagam
author_sort Gunasekaran, Gobi Hariyanayagam
title Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
title_short Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
title_full Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
title_fullStr Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
title_full_unstemmed Impact Of Traditional Prognostic Factor And Chemotherapy Schedule Modification On Breast Cancer Patients: A 5 Year Retrospective Study In A District Specialist Hospital In The State Of Perak
title_sort impact of traditional prognostic factor and chemotherapy schedule modification on breast cancer patients: a 5 year retrospective study in a district specialist hospital in the state of perak
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian Sains Farmasi
publishDate 2021
url http://eprints.usm.my/52695/1/GOBI%20HARIYANAYAGAM%20AL%20GUNASEKARAN%20-%20TESIS24.pdf
_version_ 1747822205460283392